![Jack Khattar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jack Khattar
Fondateur chez
SUPERNUS PHARMACEUTICALS, INC.
Fortune : 95 M $ au 30/09/2026
Profil
Mr. Jack A. Khattar is a President, Treasurer & Director at SAGE Therapeutics, Inc., a President, Secretary, Treasurer & Director at Adamas Pharmaceuticals LLC, a Chairman at Cognition Therapeutics, Inc., a President, CEO, Secretary & Director at Supernus Pharmaceuticals, Inc., an Advisor at New Rhein Healthcare Investors and a Chief Executive Officer at Supernus, Inc. He is on the Board of Directors at SAGE Therapeutics, Inc., Adamas Pharmaceuticals LLC and Supernus Pharmaceuticals, Inc.
Mr. Khattar was previously employed as a Chairman by scPharmaceuticals, Inc., a President, Chief Executive Officer & Director by Shire Laboratories, Inc., a Member by Shire Pharmaceuticals Group Plc, an Executive Officer by CIMA Labs, Inc., a Principal by Kodak Ltd., a Member by Licensing Executives Society, a Principal by Merck & Co., Inc., and a Principal by Novartis Corp.
He also served on the board at Navitor Pharmaceuticals, Inc., Prevacus, Inc., Rockville Economic Development, Inc. and Navitor Pharmaceuticals, Inc.
He received his undergraduate degree from American University of Beirut and an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/09/2026 | 2 216 451 ( 3,95 % ) | 95 M $ | 30/09/2026 | |
| 17/06/2026 | 73 500 ( 0,08 % ) | 70 560 $ | 30/09/2026 |
Postes actifs de Jack Khattar
| Sociétés | Poste | Début |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Fondateur | 30/03/2005 |
| COGNITION THERAPEUTICS, INC. | Président | 20/04/2021 |
| ADAMAS PHARMACEUTICALS, INC. | President | 24/11/2021 |
| SAGE THERAPEUTICS, INC. | President | 31/07/2025 |
New Rhein Healthcare Investors
 New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Consultant / Advisor | - |
Anciens postes connus de Jack Khattar
| Sociétés | Poste | Fin |
|---|---|---|
| SCPHARMACEUTICALS INC. | Président | 07/10/2025 |
Prevacus, Inc.
 Prevacus, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of mild traumatic brain injuries | Directeur/Membre du Conseil | 01/01/2020 |
Rockville Economic Development, Inc.
 Rockville Economic Development, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support for industries in the technological area and a developer for new industries | Directeur/Membre du Conseil | 01/01/2013 |
Shire Laboratories, Inc.
 Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technologies | Directeur Général | 01/01/2005 |
| ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jack Khattar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Prevacus, Inc.
Prevacus, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of mild traumatic brain injuries | Health Technology |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted therapeutics | Health Technology |
Kodak Ltd.
 Kodak Ltd. Electronics/AppliancesConsumer Durables Develops photographic, synthetic chemicals and photographic films | Consumer Durables |
American University of Beirut
 American University of Beirut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery technologies | Commercial Services |
Licensing Executives Society
 Licensing Executives Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides world leading events, useful resources and publications for deal-making, education and best practices | Commercial Services |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
Rockville Economic Development, Inc.
Rockville Economic Development, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support for industries in the technological area and a developer for new industries | Commercial Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
New Rhein Healthcare Investors
New Rhein Healthcare Investors Investment ManagersFinance New Rhein Healthcare Investors invests in companies located in the United States. The firm targets operating in the fields of of pharma and medical devices. It provides financing for seed, early and late-stage transactions. | Finance |
